A randomized phase II study of gemcitabine (G) plus the cardiac glycoside huachansu (H) in the treatment of patients with locally advanced (LAPC) or metastatic pancreatic cancer (MPC).
Z. Meng
No relevant relationships to disclose
L. Liu
No relevant relationships to disclose
Y. Shen
No relevant relationships to disclose
P. Yang
No relevant relationships to disclose
L. Cohen
No relevant relationships to disclose
Y. Huo
No relevant relationships to disclose
Q. Zhao
No relevant relationships to disclose
C. S. Ng
No relevant relationships to disclose
D. Z. Chang
No relevant relationships to disclose
C. R. Garrett
No relevant relationships to disclose